Filing Details

Accession Number:
0001683168-21-005869
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-22 08:47:56
Reporting Period:
2021-11-19
Accepted Time:
2021-11-22 08:47:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1729427 Cns Pharmaceuticals Inc. CNSP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1705978 Christopher Downs C/O Cns Pharmaceuticals, Inc.
2100 West Loop South, Suite 900
Houston TX 77027
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-19 4,500 $1.15 146,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $1.14 to $1.155. The price reported above reflects the weighted average purchaseprice. The reporting person hereby undertakes to provide upon upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number ofshares and prices at which the transaction was effected.